-
Study aim
-
Determination of Coriander Seed Effects on Glycemic Indicators, Lipid Profile and Oxidant / Antioxidant Status in Type 2 Diabetic Patients
-
Design
-
Double-blind, randomized controlled clinical trials
-
Settings and conduct
-
Patients referred to the Diabetes Clinic of Sina Hospital in Tabriz are selected according to exit criteria. All subjects participating in the study will be taken after a 12-hour fasting blood sample. The specimen will be stored at Freeze-70 until the second test. After 6 weeks of intervention, blood samples will be taken from patients again. The randomized sampling method is simple. A double-blind study, which neither the patient nor the one in charge of the capsule provides them, will not be aware of the type of capsule.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria :
Diabetic patients 30 to 60 years old, having diabetes for more than 3 years, satisfaction to participate in the project
Exit criteria:
- Smokers, pregnant, lactating, people with complex thyroid disorders, liver, digestive, cardiovascular, renal and ineffective immune systems, consumers of non-steroidal anti-inflammatory drugs and those who are homoeopathic, consumers of antioxidant supplements in the last three months , Non-controlled type 2 diabetic patients and insulin-dependent diabetic patients
-
Intervention groups
-
Coriander seed supplement
-
Main outcome variables
-
Fasting serum insulin levels, fasting blood glucose, insulin resistance, lipid profile (TC, HDL-C, TG, LDL-C), serum levels of MDA and TAC